Literature DB >> 33946985

Modulation of microRNome by Human Cytomegalovirus and Human Herpesvirus 6 Infection in Human Dermal Fibroblasts: Possible Significance in the Induction of Fibrosis in Systemic Sclerosis.

Irene Soffritti1, Maria D'Accolti1, Gloria Ravegnini2, Maria-Cristina Arcangeletti3, Clara Maccari3, Flora De Conto3, Adriana Calderaro3, Elisabetta Caselli1.   

Abstract

Human cytomegalovirus (HCMV) and Human herpesvirus 6 (HHV-6) have been reportedly suggested as triggers of the onset and/or progression of systemic sclerosis (SSc), a severe autoimmune disorder characterized by multi-organ fibrosis. The etiology and pathogenesis of SSc are still largely unknown but virological and immunological observations support a role for these beta-herpesviruses, and we recently observed a direct impact of HCMV and HHV-6 infection on the expression of cell factors associated with fibrosis at the cell level. Since miRNA expression has been found profoundly deregulated at the tissue level, here we aimed to investigate the impact on cell microRNome (miRNome) of HCMV and HHV-6 infection in in vitro infected primary human dermal fibroblasts, which represent one of the main SSc target cells. The analysis, performed by Taqman arrays detecting and quantifying 754 microRNAs (miRNAs), showed that both herpesviruses significantly modulated miRNA expression in infected cells, with evident early and late effects and deep modulation (>10 fold) of >40 miRNAs at each time post infection, including those previously recognized for their key function in fibrosis. The correlation between these in vitro results with in vivo observations is strongly suggestive of a role of HCMV and/or HHV-6 in the multistep pathogenesis of fibrosis in SSc and in the induction of fibrosis-signaling pathways finally leading to tissue fibrosis. The identification of specific miRNAs may open the way to their use as biomarkers for SSc diagnosis, assessment of disease progression and possible antifibrotic therapies.

Entities:  

Keywords:  fibrosis; human cytomegalovirus; human herpesvirus 6; miRNome; microRNA; systemic sclerosis

Year:  2021        PMID: 33946985     DOI: 10.3390/cells10051060

Source DB:  PubMed          Journal:  Cells        ISSN: 2073-4409            Impact factor:   6.600


  101 in total

1.  Severe gastrointestinal disease in very early systemic sclerosis is associated with early mortality.

Authors:  Nicolas Richard; Marie Hudson; Mianbo Wang; Geneviève Gyger; Susanna Proudman; Wendy Stevens; Mandana Nikpour; Murray Baron
Journal:  Rheumatology (Oxford)       Date:  2019-04-01       Impact factor: 7.580

2.  HHV-6 infects human aortic and heart microvascular endothelial cells, increasing their ability to secrete proinflammatory chemokines.

Authors:  Arnaldo Caruso; Antonella Rotola; Manola Comar; Flavia Favilli; Monica Galvan; Maria Tosetti; Cesare Campello; Elisabetta Caselli; Giulio Alessandri; Manuela Grassi; Emirena Garrafa; Enzo Cassai; Dario Di Luca
Journal:  J Med Virol       Date:  2002-08       Impact factor: 2.327

3.  Human cytomegalovirus (HCMV) UL44 and UL57 specific antibody responses in anti-HCMV-positive patients with systemic sclerosis.

Authors:  Emmanouela Marou; Christos Liaskos; Theodora Simopoulou; Georgios Efthymiou; Efthymios Dardiotis; Christina Katsiari; Thomas Scheper; Wolfgang Meyer; Georgios Hadjigeorgiou; Dimitrios P Bogdanos; Lazaros I Sakkas
Journal:  Clin Rheumatol       Date:  2017-01-26       Impact factor: 2.980

Review 4.  Molecular biology and clinical associations of Roseoloviruses human herpesvirus 6 and human herpesvirus 7.

Authors:  Elisabetta Caselli; Dario Di Luca
Journal:  New Microbiol       Date:  2007-07       Impact factor: 2.479

5.  Selective reactivation of human herpesvirus 6 in patients with autoimmune connective tissue diseases.

Authors:  Francesco Broccolo; Francesco Drago; Giulia Cassina; Andrea Fava; Lisa Fusetti; Barbara Matteoli; Luca Ceccherini-Nelli; Maria Grazia Sabbadini; Paolo Lusso; Aurora Parodi; Mauro S Malnati
Journal:  J Med Virol       Date:  2013-11       Impact factor: 2.327

6.  Corrigendum: Targeting miR-155 to Treat Experimental Scleroderma.

Authors:  Qingran Yan; Jie Chen; Wei Li; Chunde Bao; Qiong Fu
Journal:  Sci Rep       Date:  2016-03-04       Impact factor: 4.379

7.  Stimulation of Transforming Growth Factor-β1-Induced Endothelial-To-Mesenchymal Transition and Tissue Fibrosis by Endothelin-1 (ET-1): A Novel Profibrotic Effect of ET-1.

Authors:  Peter J Wermuth; Zhaodong Li; Fabian A Mendoza; Sergio A Jimenez
Journal:  PLoS One       Date:  2016-09-01       Impact factor: 3.240

Review 8.  Herpesviruses: Harmonious Pathogens but Relevant Cofactors in Other Diseases?

Authors:  Sharvan Sehrawat; Dhaneshwar Kumar; Barry T Rouse
Journal:  Front Cell Infect Microbiol       Date:  2018-05-25       Impact factor: 5.293

9.  Time-Resolved Small RNA Sequencing Unravels the Molecular Principles of MicroRNA Homeostasis.

Authors:  Brian Reichholf; Veronika A Herzog; Nina Fasching; Raphael A Manzenreither; Ivica Sowemimo; Stefan L Ameres
Journal:  Mol Cell       Date:  2019-07-23       Impact factor: 17.970

10.  HHV-6A Infection of Endometrial Epithelial Cells Affects miRNA Expression and Trophoblast Cell Attachment.

Authors:  Daria Bortolotti; Irene Soffritti; Maria D'Accolti; Valentina Gentili; Dario Di Luca; Roberta Rizzo; Elisabetta Caselli
Journal:  Reprod Sci       Date:  2020-01-01       Impact factor: 3.060

View more
  2 in total

1.  Human Cytomegalovirus and Human Herpesvirus 6 Coinfection of Dermal Fibroblasts Enhances the Pro-Inflammatory Pathway Predisposing to Fibrosis: The Possible Impact on Systemic Sclerosis.

Authors:  Irene Soffritti; Maria D'Accolti; Clara Maccari; Francesca Bini; Eleonora Mazziga; Flora de Conto; Adriana Calderaro; Maria-Cristina Arcangeletti; Elisabetta Caselli
Journal:  Microorganisms       Date:  2022-08-08

2.  Recent Advances in Unveiling the Role of Beta-Herpesviruses in Autoimmune Diseases.

Authors:  Maria Cristina Arcangeletti; Elisabetta Caselli
Journal:  Microorganisms       Date:  2021-12-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.